STUDIES

‘The Value of Treatment of Brain Disorders in Europe’ Research Project

Outline
Discussion Paper 1
Discussion Paper 2

Policy White Paper

Consensus Document on European Brain Research

In 2006 EBC published a Consensus Document on European Brain Research, describing needs and achievements of research in Europe and presenting proposals for future research programs. The document underwent a major revision in 2011 and another one in 2015. The present document represents an update elaborated to reflect changes in research priorities and advances in brain research that have taken place since 2006.

Consensus Document on European Brain Research 2015
Consensus Document on European Brain Research 2011
Consensus Document on European Brain Research 2006

Cost of Disorders of the Brain in Europe 2010

“Cost of disorders of the brain in Europe 2010” is the direct successor of a benchmark study of the same title published in 2005. The success of the 2005 study, in alerting European politicians and policy makers to the prevalence and high cost of brain diseases as well as the low levels of associated research funding, demanded the publication of a follow-up report. Both studies were commissioned by the European Brain Council (EBC), a co-ordinating body consisting of numerous organizations in neurology, neurosurgery, psychiatry and basic brain research (neuroscience) as well as patient groups and industrial partners.

Cost of Disorders of the Brain in Europe 2010
Cost of Disorders of the Brain in Europe 2005

Associated Studies

The economic cost of brain disorders in Europe 2010

The economic cost of brain disorders in Europe 2010 builds up on the findings from the ‘Cost of disorders of the brain in Europe 2005’ and presents updated, more accurate, and comprehensive 2010 estimates for 30 European countries. The cost model reveals that brain disorders overall are much more costly than previously estimated constituting a major health economic challenge for Europe.

Full Report

The size and burden of mental disorders and other disorders of the brain in Europe 2010

A major landmark study released on the 5th September 2011 by the European College of Neuropsychopharmacology (ECNP) sheds new light on the state of Europe’s mental and neurological health. The study finds reveal that mental disorders have become Europe’s largest health challenge in the 21st century. The study also highlights that the majority of mental disorders remain untreated. Taken together with the large and increasing number of ‘disorders of the brain’, the true size and burden is even significantly higher.

Full Report

Cost and impact of non-treating severe mental illnesses (SMIs): The case study of schizophrenia

This study is part of the broader investigation by the European Brain Council (EBC) of the cost of non-treatment of brain disorders in Europe. By providing an extensive review of the case for schizophrenia, it sheds light on the crucial issues to be looked at and provides for a robust methodology that can be translated to the other conditions to be considered in EBC’s broader study.

Full Report

Country specific papers

After a successful launch of the Cost of Disorders of the Brain in Europe 2010 EBC encourages countries participating in the European study to write country specific papers. In order to facilitate the writing of one paper per country EBC extrapolated the necessary figures and tables for each of the 30 participating European countries. They can be used together with other relevant material and literature concerning the country in question in a country specific paper to be published in a national journal in the national language.

If you would like to get involved in preparing country specific paper for your country please contact Tadeusz Hawrot, who is in charge of the administration of this project.

The following countries have published their papers:
Czech RepublicFinlandSwitzerlandUnited Kingdom

Resource Allocation for Brain Research in Europe

The EBC has worked with Stockholm Health Economics to review the current level of resource allocation to brain research in the EU. Partly funded by the EC, RABRE sought to build on the EBC’s previous finding that brain diseases represent 35% of the burden of all diseases in Europe. RABRE analysed both private and public funding of brain research in Europe, and funding sources were categorised according to both function and disease target.

Resource Allocation to Brain Research in Europe - Full report

Full Report

Resource Allocation to Brain Research in Europe – RABRE

RABRE

Research Allocation to Brain Research in Europe – Appendices

Appendices

Executive summaries are available in:

CzechEnglishEstonianFinnishFrenchGermanGreekHungarian ItalianLithuanianDutchPolishPortugueseSlovakianSpanishSwedish